Inventor · disambiguated record
Mehmet Kahraman
Also filed as: KAHRAMAN MEHMET
34 granted patents·14 pending applications·514 citations·filing 2002–2024
97Inventor score
Files withGENENTECH INC8RECURIUM IP HOLDINGS LLC7SERAGON PHARMACEUTICALS INC5KALYPSYS INC4ZENO ROYALTIES & MILESTONES LLC4
Top patents by PatentIndex Score
48 records- 0197US8455534B2Estrogen receptor modulators and uses thereofSMITH NICHOLAS D·Filed 2012·Granted Jun 4, 2013·66 cites·18 claims
- 0297US8299112B2Estrogen receptor modulators and uses thereofSMITH NICHOLAS D·Filed 2011·Granted Oct 30, 2012·72 cites·12 claims
- 0396US9475798B2Azetidine estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2015·Granted Oct 25, 2016·20 cites·14 claims
- 0496US9078871B2Estrogen receptor modulators and uses thereofSERAGON PHARMACEUTICALS INC·Filed 2013·Granted Jul 14, 2015·50 cites·22 claims
- 0596US8703810B2Estrogen receptor modulators and uses thereofKAHRAMAN MEHMET·Filed 2011·Granted Apr 22, 2014·65 cites·21 claims
- 0692US9845291B2Estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2015·Granted Dec 19, 2017·15 cites·14 claims
- 0792US8080566B1Carbazole inhibitors of histamine receptors for the treatment of diseaseKAHRAMAN MEHMET·Filed 2009·Granted Dec 20, 2011·14 cites·10 claims
- 0892US7101865B224-sulfoximine vitamin D3 compoundsUNIV JOHNS HOPKINS·Filed 2003·Granted Sep 5, 2006·49 cites·39 claims
- 0991US9873684B2Estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2015·Granted Jan 23, 2018·11 cites·16 claims
- 1091US9655880B2Azetidine estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2016·Granted May 23, 2017·5 cites·18 claims
- 1191US9193714B2Fluorinated estrogen receptor modulators and uses thereofSERAGON PHARMACEUTICALS INC·Filed 2012·Granted Nov 24, 2015·18 cites·14 claims
- 1290US6982258B2Low-calcemic oxime analogs of 1α,25-dihydroxy vitamin D3UNIV JOHNS HOPKINS·Filed 2002·Granted Jan 3, 2006·66 cites·42 claims
- 1388US9187460B2Estrogen receptor modulators and uses thereofSERAGON PHARMACEUTICALS INC·Filed 2012·Granted Nov 17, 2015·11 cites·17 claims
- 1488US7973024B224-sulfoximine vitamin D3 compoundsCYCTOCHROMA INC·Filed 2006·Granted Jul 5, 2011·20 cites·26 claims
- 1583US9586952B2Polycyclic estrogen receptor modulators and uses thereofSERAGON PHARMACEUTICALS INC·Filed 2014·Granted Mar 7, 2017·7 cites·37 claims
- 1683US9399646B2Estrogen receptor modulators and uses thereofSMITH NICHOLAS D·Filed 2011·Granted Jul 26, 2016·6 cites·15 claims
- 1782US10525036B2Spirocyclic compoundsRECURIUM IP HOLDINGS LLC·Filed 2016·Granted Jan 7, 2020·2 cites·23 claims
- 1882US7494999B2Sulfonyl-substituted bicyclic compounds as modulators of PPARKALYPSYS INC·Filed 2005·Granted Feb 24, 2009·6 cites·9 claims
- 1980US11504367B2Compounds and methods for treating oxalate-related diseasesOXALURX INC·Filed 2020·Granted Nov 22, 2022·1 cites·25 claims
- 2078US9499538B2Estrogen receptor modulators and uses thereofSERAGON PHARMACEUTICALS INC·Filed 2013·Granted Nov 22, 2016·4 cites·13 claims
- 2177US10053451B2Heterocyclic estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2016·Granted Aug 21, 2018·2 cites·10 claims
- 2277US2025179059A1Anticancer compoundsUNIV CALIFORNIA·Filed 2024·Application pending·0 cites
- 2377US2025186441A1Compounds and methods for treating oxalate-related diseasesOXALURX INC·Filed 2024·Application pending·0 cites
- 2475US10308609B2Bicyclic compoundsKALYRA PHARMACEUTICALS INC·Filed 2015·Granted Jun 4, 2019·2 cites·22 claims
- 2574US12213976B2Compounds and methods for treating oxalate-related diseasesOXALURX INC·Filed 2022·Granted Feb 4, 2025·0 cites·34 claims
- 2671US12162870B2Anticancer compoundsUNIV CALIFORNIA·Filed 2022·Granted Dec 10, 2024·0 cites·34 claims
- 2771US10975035B2Bicyclic compoundsRECURIUM IP HOLDINGS LLC·Filed 2019·Granted Apr 13, 2021·0 cites·25 claims
- 2871US10493060B2Spirocyclic compoundsZENO ROYALTIES & MILESTONES LLC·Filed 2019·Granted Dec 3, 2019·1 cites·11 claims
- 2971US7834004B2Sulfonyl-substituted bicyclic compounds as modulators of PPARKALYPSYS INC·Filed 2008·Granted Nov 16, 2010·1 cites·37 claims
- 3067US2024208939A1Treatment of autoimmune and inflammatory disorders with inhibitors of bet family bdii bromodomainPOSEIDON INNOVATION 1 INC·Filed 2023·Application pending·0 cites
- 3167US2024226096A1Treatment of myeloproliferative diseases and disorders with inhibitors of bet family bdii bromodomainPOSEIDON INNOVATION 1 INC·Filed 2023·Application pending·0 cites
- 3265US2024217952A1Treatment of graft-versus-host disease with inhibitors of bet family bdii bromodomainPOSEIDON INNOVATION 1 INC·Filed 2023·Application pending·0 cites
- 3363US2020268714A1Spirocyclic compoundsRECURIUM IP HOLDINGS LLC·Filed 2020·Application pending·0 cites
- 3462US2021115058A1Spirocyclic compoundsRECURIUM IP HOLDINGS LLC·Filed 2020·Application pending·0 cites
- 3560US10934304B2Spirocyclic compoundsRECURIUM IP HOLDINGS LLC·Filed 2017·Granted Mar 2, 2021·0 cites·23 claims
- 3660US9868704B2Estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2016·Granted Jan 16, 2018·0 cites·18 claims
- 3759US7915253B2Sulfonyl-substituted bicyclic compounds as modulators of PPARKALYPSYS INC·Filed 2008·Granted Mar 29, 2011·0 cites·40 claims
- 3854US10653681B2Analgesic compoundsRECURIUM IP HOLDINGS LLC·Filed 2017·Granted May 19, 2020·0 cites·12 claims
- 3954US10227334B2Estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2017·Granted Mar 12, 2019·0 cites·2 claims
- 4053US2008021026A1Benzothiophene inhibitors of rho kinaseKAHRAMAN MEHMET·Filed 2007·Application pending·0 cites
- 4153US2008021217A1Heterocyclic inhibitors of rho kinaseBORCHARDT ALLEN J·Filed 2007·Application pending·0 cites
- 4252US2006252807A1Novel ortho-terphenyl inhibitors of p38 kinase and methods of treating inflammatory disordersKALYPSYS INC·Filed 2006·Application pending·0 cites
- 4346US11242327B2Analgesic compoundsRECURIUM IP HOLDINGS LLC·Filed 2018·Granted Feb 8, 2022·0 cites·23 claims
- 4440US8906888B2Low-calcemic 16,23-diene 25-oxime analogs of 1α,25-dihydroxy vitamin D3SAHA UTTAM·Filed 2006·Granted Dec 9, 2014·0 cites·23 claims
- 4539US2019083460A1Analgesic compoundsZENO ROYALTIES & MILESTONES LLC·Filed 2017·Application pending·0 cites
- 4639US2019060257A1Analgesic compoundsZENO ROYALTIES & MILESTONES LLC·Filed 2017·Application pending·0 cites
- 4739US2019099404A1Analgesic compoundsZENO ROYALTIES & MILESTONES LLC·Filed 2017·Application pending·0 cites
- 4837US2016175284A1Estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mehmet Kahraman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →